Skip to Main Content

Paper Details

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer.
Gynecol Oncol
4
2021
Author NameAffiliation
Gottfried E KonecnyUniversity of California Los Angeles
Boris WinterhoffUniversity of Minnesota
Sven MahnerUniversity Hospital Hamburg-Eppendorf
Peter A FaschingUniversity of Erlangen
Isabelle Ray-Coquard
Paul Haluska
Dennis J SlamonUniversity of California Los Angeles
  • 1 - 7

Datasets

Release 1.2